🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Summary In patients with prostate cancer (PC) who have only biochemically ...
Status
Unknown
Location
Copenhagen University hospital, Rigshospitalet
Start Date
2009-02
Trial ID
NCT03119857
Treatments Being Tested
This trial is conducted in South Africa. The aim of this trial is to invest...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2002-03-20
Trial ID
NCT01486381
Treatments Being Tested
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
This is a Phase II parallel group randomized controlled trial with 294 adol...
Status
Recruiting
Location
UConn Health
Start Date
2024-11-26
Trial ID
NCT06395467
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
This study evaluated the effects of a multidisciplinary biopsychosocial pro...
Status
Completed
Location
University Hospital Osijek
Start Date
2021-11-15
Trial ID
NCT07406711
Treatments Being Tested
Study to determine the effect of multiple-dose BBT-877 on the single-dose p...
Status
Completed
Location
Celerion
Start Date
2019-09-17
Trial ID
NCT04138836
Treatments Being Tested
The aim of this study is to compare the effect of antioxidant dressing (act...
Status
Completed
Location
Universidad de Jaén
Start Date
2019-09-02
Trial ID
NCT03934671
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested